These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9180290)

  • 21. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia].
    Tanabe Y; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma.
    Visani G; Lemoli RM; Tosi P; Verlicchi F; Gamberi B; Cenacchi AR; Colombini R; Fogli M; Russo D; Zuffa E
    Blut; 1990 May; 60(5):287-90. PubMed ID: 2112414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alpha interferon on growth of leukemic and normal hematopoietic progenitors. Synergism with H2 histamine receptor antagonists.
    Douer D; Kneller A; Ben-Bassat I; Chitayat SD; Shaked N; Salzberg S; Ramot B
    Exp Hematol; 1989 Jun; 17(5):443-8. PubMed ID: 2714424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Langenhuijsen MM; Ossenkoppele GJ
    Leukemia; 1997 Feb; 11(2):301-5. PubMed ID: 9009097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antisense oligonucleotides on CD34+ cells from chronic myeloid leukemia.
    Pigneux A; Mahon FX; Jazwiec B; Pigeonnier V; Ripoche J; Reiffers J
    Leuk Lymphoma; 2000 Feb; 36(5-6):569-78. PubMed ID: 10784402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
    Sagayadan GE; Wiernik PH; Sun N; Ahearn G; Thompson D; Hallam SJ; Hu XP; Dutcher JP; Gallagher RE
    Leuk Res; 1994 Oct; 18(10):741-8. PubMed ID: 7934131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
    Korycka A; Robak T
    Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
    Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
    Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alpha in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.
    Russo D; Tell G; Marin L; Tiribelli M; Santucci MA; Pucillo C
    Haematologica; 1999 Oct; 84(10):955-7. PubMed ID: 10509049
    [No Abstract]   [Full Text] [Related]  

  • 35. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
    Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
    Wandl UB; Niederle N; Kranzhoff M; Seeber S
    Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors.
    Galvani DW; Cawley JC
    Br J Haematol; 1989 Dec; 73(4):475-9. PubMed ID: 2611135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside.
    Stagno F; Guglielmo P; Consoli U; Inghilterra G; Giustolisi GM; Palumbo GA; Giustolisi R
    Acta Haematol; 2000; 104(2-3):57-64. PubMed ID: 11154976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
    Müller-Tidow C; Kiehl M; Sindermann JR; Probst M; Banger N; Zühlsdorf M; Chou TC; Berdel WE; Serve H; Koch OM
    Int J Oncol; 2003 Jul; 23(1):151-8. PubMed ID: 12792788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.